Related references
Note: Only part of the references are listed.SLC7A11 expression is associated with seizures and predicts poor survival in patients with malignant glioma
Stephanie M. Robert et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo
Sriram Venneti et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Cysteine Catabolism: A Novel Metabolic Pathway Contributing to Glioblastoma Growth
Antony Prabhu et al.
CANCER RESEARCH (2014)
Glutamate transporters in the biology of malignant gliomas
Stephanie M. Robert et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
Functional Imaging of Oxidative Stress with a Novel PET Imaging Agent, 18F-5-Fluoro-L- Aminosuberic Acid
Jack M. Webster et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Comparison of the Amino Acid Tracers 18F-FET and 18F-DOPA in High-Grade Glioma Patients
Constantin Lapa et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
The Use of Longitudinal 18F-FET MicroPET Imaging to Evaluate Response to Irinotecan in Orthotopic Human Glioblastoma Multiforme Xenografts
Mette K. Nedergaard et al.
PLOS ONE (2014)
Disruption of astrocyte-vascular coupling and the blood-brain barrier by invading glioma cells
Stacey Watkins et al.
NATURE COMMUNICATIONS (2014)
(4S)-4-(3-18F-Fluoropropyl)-L-Glutamate for Imaging of xC- Transporter Activity in Hepatocellular Carcinoma Using PET: Preclinical and Exploratory Clinical Studies
Sora Baek et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
(S)-4-(3-18F-Fluoropropyl)-L-Glutamic Acid: An 18F-Labeled Tumor-Specific Probe for PET/CT Imaging-Dosimetry
Kamilla Smolarz et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Increased xCT Expression Correlates With Tumor Invasion and Outcome in Patients With Glioblastomas
Satoru Takeuchi et al.
NEUROSURGERY (2013)
Progress on the diagnosis and evaluation of brain tumors
Huila Gao et al.
CANCER IMAGING (2013)
System xc- cystine/glutamate antiporter: an update on molecular pharmacology and roles within the CNS
Richard J. Bridges et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Exploratory Clinical Trial of (4S)-4-(3-[18F]fluoropropyl)-L-glutamate for Imaging xC Transporter Using Positron Emission Tomography in Patients with Non-Small Cell Lung or Breast Cancer
Sora Baek et al.
CLINICAL CANCER RESEARCH (2012)
CD44 Variant Regulates Redox Status in Cancer Cells by Stabilizing the xCT Subunit of System xc- and Thereby Promotes Tumor Growth
Takatsugu Ishimoto et al.
CANCER CELL (2011)
Specific PET Imaging of xC- Transporter Activity Using a 18F-Labeled Glutamate Derivative Reveals a Dominant Pathway in Tumor Metabolism
Norman Koglin et al.
CLINICAL CANCER RESEARCH (2011)
Malignant Gliomas: Diagnosis and Treatment
Sherise D. Ferguson
DM DISEASE-A-MONTH (2011)
Multimodality Assessment of Brain Tumors and Tumor Recurrence
Wolf-Dieter Heiss et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Molecular imaging of gliomas with PET: Opportunities and limitations
Christian la Fougere et al.
NEURO-ONCOLOGY (2011)
Glioma recurrence versus radiation necrosis: accuracy of current imaging modalities
George A. Alexiou et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
18F-FDG PET/CT evaluation of patients with ovarian carcinoma
Andrei H. Iagaru et al.
NUCLEAR MEDICINE COMMUNICATIONS (2008)
Autocrine glutamate signaling promotes glioma cell invasion
Susan A. Lyons et al.
CANCER RESEARCH (2007)
Cooperative action of glutamate transporters and cystine/glutamate antiporter system Xc- protects from oxidative glutamate toxicity
Jan Lewerenz et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Share Paper
